Posted by Michael Wonder on 13 Oct 2022
Amgen's annual trends report finds competition created by biosimilars contributed $21 billion in US health care system savings
12 October 2022 - Ninth Edition of Amgen's Biosimilar Trends Report Examines the U.S. and Global Marketplace with Biosimilars.
Amgen today released the ninth edition of its Biosimilar Trends Report, which examines the current and future state of the US marketplace with biosimilars.
This year, in addition to examining important trends in the US, the Report also highlights key considerations and learnings from the global marketplace with biosimilars.
